Twist Bioscience (TWST)
(Delayed Data from NSDQ)
$31.54 USD
+0.46 (1.48%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $31.53 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for Twist Bioscience Corporation falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 245 | 204 | 132 | 90 | 54 |
Cost Of Goods | 155 | 119 | 81 | 61 | 47 |
Gross Profit | 90 | 84 | 52 | 29 | 7 |
Selling & Adminstrative & Depr. & Amort Expenses | 307 | 319 | 204 | 169 | 116 |
Income After Depreciation & Amortization | -217 | -235 | -153 | -140 | -109 |
Non-Operating Income | 14 | 7 | -1 | 1 | 3 |
Interest Expense | 0 | 0 | 0 | 1 | 1 |
Pretax Income | -203 | -228 | -154 | -140 | -107 |
Income Taxes | 1 | -10 | -2 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -205 | -218 | -152 | -140 | -108 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -205 | -218 | -152 | -140 | -108 |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -188 | -218 | -143 | -133 | -102 |
Depreciation & Amortization (Cash Flow) | 29 | 17 | 10 | 7 | 6 |
Income After Depreciation & Amortization | -217 | -235 | -153 | -140 | -109 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | 56.89 | 53.89 | 48.25 | 39.19 | 27.46 |
Diluted EPS Before Non-Recurring Items | -3.62 | -4.15 | -3.15 | -3.00 | -3.92 |
Diluted Net EPS (GAAP) | -3.60 | -4.04 | -3.15 | -3.57 | -3.92 |
Fiscal Year end for Twist Bioscience Corporation falls in the month of September.
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 71.50 | 66.95 | 63.74 | 60.18 |
Cost Of Goods | NA | 42.54 | 42.42 | 41.85 | 41.67 |
Gross Profit | NA | 28.96 | 24.52 | 21.90 | 18.51 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 75.94 | 74.64 | 82.68 | 80.15 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -46.98 | -50.12 | -60.78 | -61.64 |
Non-Operating Income | NA | 4.09 | 3.65 | 4.01 | 3.16 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -42.89 | -46.47 | -56.77 | -58.48 |
Income Taxes | NA | 0.12 | -0.22 | 0.62 | 0.68 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -43.01 | -46.24 | -57.40 | -59.16 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -43.01 | -46.24 | -57.40 | -59.16 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 57.50 | 57.28 | 57.04 | 56.78 |
Diluted EPS Before Non-Recurring Items | NA | -0.75 | -0.81 | -1.01 | -1.06 |
Diluted Net EPS (GAAP) | NA | -0.75 | -0.81 | -1.01 | -1.04 |